Pharmafile Logo
Pharmafocus logo
Advanced Search
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 14, 2021
Medical Communications

Among our ten most-read stories this week: India recoded its record number of COVID-19 deaths, with 4,205 fatalities confirmed in …

News

MSD’s colorectal cancer treatment approved by NICE

May 14, 2021
Medical Communications

Pembrolizumab (Keytruda), for people with untreated metastatic colorectal cancer who have specific mutations in their cancer cells, has been approved …

News
Pfizer sign

Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows

May 14, 2021
Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news

The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …

News
biogen_austria_238

Biogen to collaborate with Envisagenics on RNA splicing research

May 14, 2021
Medical Communications AI

Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …

News

Major ovarian cancer screening trial fails to reduce deaths

May 14, 2021
Medical Communications

A major trial involving 200,000 women to detect ovarian cancer has failed to save lives after two decades of work. …

News

India approves Covaxin clinical trials for children aged 2-18 years old

May 13, 2021

The Drugs Controller General of India (DCGI) has cleared Bharat Biotech’s Covaxin trials on children from 2-18 years old. The …

News
Amgen flag

AstraZeneca and Amgen asthma drug shows positive results in Phase III trial

May 13, 2021
Amgen, AstraZeneca, asthma, asthma treatment, pharma, pharma news, severe asthma

AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority across all primary and secondary …

News
sanofi_hq__boetie_hall_web

Sanofi’s Libtayo shows positive Phase III results in advanced cervical cancer

May 13, 2021
Libtayo, Sanofi, cemiplimab, cervical cancer

Regeneron Pharmaceuticals and Sanofi have announced today positive Phase III trial results investigating the PD-1 inhibitor Libtayo (cemiplimab) in patients …

News

Rinri Therapeutics secures £3.2 million grant for hearing loss therapy

May 13, 2021
Stem cells

Sheffield-based biotech company, Rinri Therapeutics, have secured a £3.2 million grant from Innovate UK to further develop Rinri’s novel stem …

News

Exscientia launch trial of third AI-designed molecule

May 13, 2021
AI, Altzeimer's, Exscientia

Exscientia has launched Phase I trials in the US of DSP-0038 for the treatment of Alzheimer’s disease psychosis, the third …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

May 12, 2021
Research and Development COVID-19

The past week has seen India’s highest number of COVID-19 deaths, with 4,205 fatalities in a single day. There has …

News

India report record number of COVID deaths as bodies drift down Ganges

May 12, 2021
Research and Development COVID-19, India, Indian COVID crisis, covid 19 news, covid-19 news, pharma, pharma news

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.

News
MHRA sign

Astellas prostate cancer drug gets third approval from MHRA

May 12, 2021
Research and Development Astellas, MHRA, cancer research, cancer treatment, pharma, pharma news, prostate cancer

The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …

News

NICE rejects Pfizer’s Vyndaqel for treating rare heart condition

May 12, 2021
Research and Development NICE, Pfizer, Vyandaqel

NICE has published final guidance today which rejects tafamidis, also known as Vyndaqel, for treating rare heart condition transthyretin amyloidosis …

News

Endogena’s retinitis pigmentosa treatment granted Orphan Drug Designation by FDA

May 12, 2021
Research and Development DFA, Endogena, Orphan Drug Designation

Endogena Therapeutics Inc has been granted Orphan Drug Designation for its EA-2353 ophthalmic suspension targeting retinitis pigmentosa by the FDA. …

News

Eli Lilly and MiNA Therapeutics to collaborate on saRNA research

May 12, 2021
Research and Development Eli Lilly

Eli Lilly and MiNA Therapeutics have announced a global research collaboration to develop novel drug candidates using MiNA’s proprietary small …

News

Bayer’s cardiovascular drug shows impressive Phase III results

May 11, 2021
Manufacturing and Production Bayer, chronic kidney disease, pharma, pharma news, type 2 diabetes

Bayer’s finerenone drug has been shown to significantly reduce cardiovascular death or other cardiovascular events in patients with chronic kidney …

News
NHS building

Abbvie psoriatic arthritis drug approved for use in Scotland

May 11, 2021
Manufacturing and Production AbbVie, NHS, arthritis, psoriatic arthritis

Abbvie’s RINVOQ (upadacitinib) drug, for the treatment of active psoriatic arthritis (PsA) in adults, has been approved for use in …

News
pfizer

FDA authorizes use of Pfizer vaccine for children aged 12-15

May 11, 2021
Manufacturing and Production COVID-19, FDA, Pfizer, Vaccine

The FDA announced it has expanded the emergency use of the Pfizer-BioNTech vaccine in children aged 12-15 yesterday.It was determined …

News

Facio Therapies announces AI collaboration for FSHD drug design

May 11, 2021
Manufacturing and Production AI, drug discovery

Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026